Conduit Pharmaceuticals (CDT) announces that, following confirmation of compliance with the Bid Price and Equity Requirements as detailed in the announcement dated May 21, the Company received formal notice from The Nasdaq Stock Market that the Company’s application to transfer the listing of its common stock to The Nasdaq Capital Market has been approved and the Company’s securities will be transferred to The Nasdaq Capital Market at the opening of business on May 23.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CDT:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue